Can an on­colyt­ic virus ther­a­py chal­lenge the stan­dard of care in blad­der can­cer? CG On­col­o­gy has $120M to find out

CG On­col­o­gy is cash­ing in on its in­ter­im da­ta up­date.

Tues­day morn­ing, the Irvine, CA-based biotech an­nounced that it raised $120 mil­lion — eclips­ing the com­bined …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER